Raymond James Has Lowered Expectations for Johnson

Jan 23, 2025 · Raymond James Has Lowered Expectations for Johnson & Johnson (NYSE:JNJ) Stock Price. Written by MarketBeat. January 23, 2025. ... Johnson & Johnson has a 1 year low …

CouponFollow Extension

$165
OFF

Johnson & Johnson Price Target Lowered To $165 From $170 At …

3 weeks from now

Jan 23, 2025 · Raymond James lowered the firm’s price target on Johnson & Johnson to $165 from $170 and keeps an Outperform rating on the shares. J&J’s Q4 results were solid, and its …

businessinsider.com

$152
OFF

Johnson & Johnson Price Target Lowered To $152 From $166 At …

3 weeks from now

Jan 23, 2025 · Johnson & Johnson price target lowered to $152 from $166 at Wells Fargo. TipRanks. Jan. 23, 2025, 05:20 AM. ... Johnson & Johnson price target lowered to $165 from …

businessinsider.com

$2.04
OFF

Johnson & Johnson (JNJ) Stock Forecast And Price Target 2025

3 weeks from now

6 days ago · Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating: ... Johnson & Johnson reported earnings per share of $2.04, exceeding …

marketbeat.com

3%
OFF

Raymond James Adjusts Johnson & Johnson Price Target To $165 …

3 weeks from now

Jan 23, 2025 · Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.3%): …

marketscreener.com

$165.00
OFF

Where Johnson & Johnson Stands With Analysts - Nasdaq

3 weeks from now

Jan 23, 2025 · Ratings for Johnson & Johnson ... Raymond James: Lowers: Outperform: $165.00: $170.00: ... These ratings convey expectations for the relative performance of Johnson & …

nasdaq.com

$193.94
OFF

What Analysts Are Saying About Johnson & Johnson Stock

3 weeks from now

Oct 10, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Johnson & Johnson, presenting an average target of $193.94, a high estimate of $215.00, and a low …

nasdaq.com

20%
OFF

2025 Investing Outlook - Raymond James

3 weeks from now

Jan 2, 2025 · Dial back equity market expectations. For the first time since the late 1990s, the S&P 500 posted consecutive annual returns of more than 20%. ... All expressions of opinion …

raymondjames.com

$169.00
OFF

Raymond James (RJF) Stock Forecast And Price Target 2025

3 weeks from now

Wells Fargo recently lowered its price target for Raymond James from $169.00 to $168.00, indicating a cautious outlook from some analysts. Insider selling has been observed, with …

marketbeat.com

$191
OFF

Beyond The Numbers: 13 Analysts Discuss Johnson & Johnson Stock

3 weeks from now

Feb 28, 2024 · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $191.0, along with a high estimate of $215.00 and a low …

businessinsider.com

$128.72
OFF

Raymond James Has Lowered Expectations For United Parcel

3 weeks from now

2 days ago · The company's 50 day moving average price is $128.72 and its two-hundred day moving average price is $130.61. United Parcel Service has a one year low of $109.62 and a …

marketbeat.com

$30.00
OFF

Raymond James Has Lowered Expectations For Interfor (TSE:IFP) …

3 weeks from now

1 day ago · Interfor (TSE:IFP – Get Free Report) had its price objective cut by investment analysts at Raymond James from C$30.00 to C$26.00 in a report issued on Thursday,BayStreet.CA …

defenseworld.net

$6.32
OFF

Raymond James Has Lowered Expectations For Doman Building

3 weeks from now

2 days ago · Doman Building Materials Group has a 12-month low of C$6.32 and a 12-month high of C$9.96. The company has a debt-to-equity ratio of 132.33, a quick ratio of 1.11 and a …

marketbeat.com

$125.00
OFF

Truist Financial Has Lowered Expectations For Prologis

3 weeks from now

Jan 18, 2025 · Raymond James restated an "outperform" rating and issued a $125.00 price objective (down previously from $130.00) on shares of Prologis in a report on Wednesday, …

marketbeat.com

FAQs about Raymond James Has Lowered Expectations for Johnson Coupon?

What should you expect from Raymond James in 2024?

Raymond James Chief Investment Officer Larry Adam shares 10 key themes to watch in the coming year. He anticipates challenges and volatility spikes, requiring careful portfolio decisions, but believes that the momentum will ultimately continue. Too much optimism? Consumer, business and investor confidence all saw boosts following the 2024 election. ...

How do financial analysts perceive Johnson & Johnson?

The perception of Johnson & Johnson by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. ...

What is the average price target for Johnson & Johnson?

In the assessment of 12-month price targets, analysts unveil insights for Johnson & Johnson, presenting an average target of $193.94, a high estimate of $215.00, and a low estimate of $150.00. This current average has decreased by 0.6% from the previous average price target of $195.12. Investigating Analyst Ratings: An Elaborate Study ...

What happened to Johnson & Johnson?

Stay up to date on Johnson & Johnson analyst ratings. All You Need to Know About Johnson & Johnson Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. ...

Does Johnson & Johnson (J&J) have a strong market position?

Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position. Revenue Growth: Johnson & Johnson's revenue growth over a period of 3 months has been noteworthy. ...

How do analysts evaluate Johnson & Johnson's stock?

Price Targets: Gaining insights, analysts provide estimates for the future value of Johnson & Johnson's stock. This comparison reveals trends in analysts' expectations over time. Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Johnson & Johnson's market position. ...